FDA PERSPECTIVE: ADVANCED MANUFACTURING AND THE FUTURE OF PHARMACEUTICAL QUALITY In the opening remarks, Michael Kopcha, Director of the Office of Pharmaceutical Quality (OPQ), offered CDER’s ...
Join our daily and weekly newsletters for the latest updates and exclusive content on industry-leading AI coverage. Learn More Digital twins — a digital replica of the factory floor — are an important ...
While braille is mandatory on all pharmaceutical packaging in Europe, U.S. regulatory agencies remain quiet on the issue, according to Pharmaceutical Processing. The U.S. Food and Drug Administration ...
Pharmaceutical Contract Development And Manufacturing Organization Cdmo Market Pharmaceutical Contract Development · GlobeNewswire Inc. Dublin, Feb. 03, 2026 (GLOBE NEWSWIRE) -- The "Pharmaceutical ...
Process development is the exercise of creating new and improved manufacturing methods, optimizing them in terms of time and financial efficiency while maintaining regulatory compliance and product ...
Technological innovations throughout the past several decades have transformed the pharmaceutical manufacturing process from traditional batch production to ...
How CDMOs are reshaping pharmaceutical partnerships through friendshoring, risk-sharing economics, and specialized development capabilities. The pharmaceutical manufacturing landscape is undergoing a ...
Section 1. Purpose. During my first term, my Administration took unprecedented action to improve the well-being of the American people by restoring capacity for domestic production of critical ...
LONDON--(BUSINESS WIRE)--The pharmaceutical manufacturing industry is considered one of the top 10 industries with the highest barriers to entry. Issues such as high R&D costs, challenging regulatory ...
The pharmaceutical industry is one of the most relevant sectors in today's economy. For more than a century, pharmaceutical production has relied on batch production, but this lacks the agility, ...
As the demand for biologics accelerates, biopharma companies are under pressure to expand sterile manufacturing capacity ...
In the opening remarks, Michael Kopcha, Director of the Office of Pharmaceutical Quality (OPQ), offered CDER’s perspective on advanced manufacturing and pharmaceutical quality. He began the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results